bpc 157 liposomal - 1 fl. oz (30 ml) - Quicksilver Scientific BP-157 oral Liposomal *** This

HCC / Risk Adjustment (v28) Under the CMS-HCC Model v28 (effective for payment year 2026), Crohns disease and associated conditions map to the following Hierarchical Condition Categories: For Medicare Advantage patients with Crohns disease, annual risk adjustment requires recapture of HCC 35 (IBD) each calendar year

Disclaimer The Marham platform strives to offer expert reviewed information, which includes error elimination for all its consumers

Batch documentation is available where applicable through the COA Reports page or customer support

Using your mixing syringe, pull out 5mls of your mixing solution and insert into your bottle of powdered hcg

Ryan-Harshman M, Aldoori W